Sensor, Glucose, Invasive, Component Of Automated Insulin Delivery System
SFI is the FDA product code for Sensor, Glucose, Invasive, Component Of Automated Insulin Delivery System, a class III device type. FDA's definition for this code reads: "The device is intended to measure glucose in interstitial fluid. It is intended to provide those measurements as inputs to appropriately qualified digitally connected devices, including automated insulin dosing systems, as determined by FDA". As of , FDA records hold no 510(k) clearances under this code and no recalls.
Classification record
- Product code
- SFI
- Device name
- Sensor, Glucose, Invasive, Component Of Automated Insulin Delivery System
- FDA definition
- The device is intended to measure glucose in interstitial fluid. It is intended to provide those measurements as inputs to appropriately qualified digitally connected devices, including automated insulin dosing systems, as determined by FDA.
- Device class
- Class III
- Review panel
- Unknown
- Submission type
- PMA
- Implant
- No
- Life sustaining or supporting
- No
- GMP exempt
- No
- Third party review eligible
- No
- Ingested clearances
- 0
- Ingested recalls
- 0
Companies listing this code with FDA
Companies whose registered establishments list this codeFIRST ARTICLE / WEEKLY
What cleared, what was recalled, and what changed in the standards. One edition a week for the people who make medical devices.
